LAVTX
Price
$15.88
Change
+$0.09 (+0.57%)
Updated
Jan 17 closing price
Net Assets
1.99B
VIVIX
Price
$68.15
Change
+$0.43 (+0.63%)
Updated
Jan 17 closing price
Net Assets
183.52B
Ad is loading...

LAVTX vs VIVIX

Header iconLAVTX vs VIVIX Comparison
Open Charts LAVTX vs VIVIXBanner chart's image
Lord Abbett Fundamental Equity R5
Price$15.88
Change+$0.09 (+0.57%)
VolumeN/A
Net Assets1.99B
Vanguard Value Index I
Price$68.15
Change+$0.43 (+0.63%)
VolumeN/A
Net Assets183.52B
LAVTX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVTX vs. VIVIX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVTX is a Hold and VIVIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. LAVTX (1.99B). VIVIX pays higher dividends than LAVTX: VIVIX (2.37) vs LAVTX (0.94). LAVTX was incepted earlier than VIVIX: LAVTX (10 years) vs VIVIX (27 years). LAVTX is a more actively managed with annual turnover of: 26.00 vs. VIVIX (10.00). LAVTX has a lower initial minimum investment than VIVIX: LAVTX (0) vs VIVIX (5000000). LAVTX annual gain was more profitable for investors over the last year : 19.98 vs. VIVIX (18.21). VIVIX return over 5 years is better than : 44.19 vs. LAVTX (34.64).
LAVTXVIVIXLAVTX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years27 years-
Gain YTD4.4743.211139%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.99B184B1%
Annual Yield % from dividends0.942.3740%
Returns for 1 year19.9818.21110%
Returns for 3 years17.6418.4696%
Returns for 5 years34.6444.1978%
Returns for 10 yearsN/A111.13-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCDGX35.020.33
+0.95%
DWS Core Equity S
IJSIX16.970.08
+0.47%
VY® JPMorgan Small Cap Core Equity I
DBMAX28.370.05
+0.18%
BNY Mellon Sm/Md Cp Gr A
TEOIX7.88N/A
N/A
Transamerica Emerging Markets Eq I
PHPSX20.95-0.18
-0.85%
ProFunds Pharmaceuticals UltraSector Svc